Literature DB >> 28344876

2B4-SAP signaling is required for the priming of naive CD8+ T cells by antigen-expressing B cells and B lymphoma cells.

Yu-Hsuan Huang1, Kevin Tsai1, Sara Y Tan1, Sohyeong Kang1, Mandy L Ford2, Kenneth W Harder3, John J Priatel1.   

Abstract

Mutations in SH2D1A gene that encodes SAP (SLAM-associated protein) result in X-linked lymphoproliferative disease (XLP), a rare primary immunodeficiency disease defined by exquisite sensitivity to the B-lymphotropic Epstein-Barr virus (EBV) and B cell lymphomas. However, the precise mechanism of how the loss of SAP function contributes to extreme vulnerability to EBV and the development of B cell lymphomas remains unclear. Here, we investigate the hypothesis that SAP is critical for CD8+ T cell immune surveillance of antigen (Ag)-expressing B cells or B lymphoma cells under conditions of defined T cell receptor (TCR) signaling. Sh2d1a-/- CD8+ T cells exhibited greatly diminished proliferation relative to wild type when Ag-presenting-B cells or -B lymphoma cells served as the primary Ag-presenting cell (APC). By contrast, Sh2d1a-/- CD8+ T cells responded equivalently to wild-type CD8+ T cells when B cell-depleted splenocytes, melanoma cells or breast carcinoma cells performed Ag presentation. Through application of signaling lymphocyte activation molecule (SLAM) family receptor blocking antibodies or SLAM family receptor-deficient CD8+ T cells and APCs, we found that CD48 engagement on the B cell surface by 2B4 is crucial for initiating SAP-dependent signaling required for the Ag-driven CD8+ T cell proliferation and differentiation. Altogether, a pivotal role for SAP in promoting the expansion and differentiation of B cell-primed viral-specific naive CD8+ T cells may explain the selective immune deficiency of XLP patients to EBV and B cell lymphomas.

Entities:  

Keywords:  Antigen-presenting cells; B cell lymphoma; B cells; CD8+ T cells; Epstein–Barr virus; SLAM family receptors; SLAM-associated protein; T cell receptor; X-linked proliferative disease; immune deficiency

Year:  2016        PMID: 28344876      PMCID: PMC5353922          DOI: 10.1080/2162402X.2016.1267094

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  51 in total

1.  Regulation of NKT cell development by SAP, the protein defective in XLP.

Authors:  Kim E Nichols; Jamie Hom; Shun-You Gong; Arupa Ganguly; Cindy S Ma; Jennifer L Cannons; Stuart G Tangye; Pamela L Schwartzberg; Gary A Koretzky; Paul L Stein
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

2.  RasGRP1 regulates antigen-induced developmental programming by naive CD8 T cells.

Authors:  John J Priatel; Xiaoxi Chen; Yu-Hsuan Huang; Michael T Chow; Lauren A Zenewicz; Jason J Coughlin; Hao Shen; James C Stone; Rusung Tan; Hung Sia Teh
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

3.  Rapid deletion and inactivation of CTLs upon recognition of a number of target cells over a critical threshold.

Authors:  Sandro Prato; Yifan Zhan; Justine D Mintern; Jose A Villadangos
Journal:  J Immunol       Date:  2013-09-09       Impact factor: 5.422

4.  Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice.

Authors:  Gang Chen; Albert K Tai; Miao Lin; Francesca Chang; Cox Terhorst; Brigitte T Huber
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

Review 5.  Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.

Authors:  Kim E Nichols; Cindy S Ma; Jennifer L Cannons; Pamela L Schwartzberg; Stuart G Tangye
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

6.  Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84.

Authors:  Jennifer L Cannons; Hai Qi; Kristina T Lu; Mala Dutta; Julio Gomez-Rodriguez; Jun Cheng; Edward K Wakeland; Ronald N Germain; Pamela L Schwartzberg
Journal:  Immunity       Date:  2010-02-11       Impact factor: 31.745

7.  SAP expression in T cells, not in B cells, is required for humoral immunity.

Authors:  André Veillette; Shaohua Zhang; Xiaochu Shi; Zhongjun Dong; Dominique Davidson; Ming-Chao Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-22       Impact factor: 11.205

8.  Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and hox gene expression in hematopoietic cells.

Authors:  Alexander Sio; Manreet K Chehal; Kevin Tsai; Xueling Fan; Morgan E Roberts; Brad H Nelson; Jolanta Grembecka; Tomasz Cierpicki; Danielle L Krebs; Kenneth W Harder
Journal:  Cancer Res       Date:  2013-08-01       Impact factor: 12.701

9.  Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product.

Authors:  Benoit Pasquier; Luo Yin; Marie-Claude Fondanèche; Francis Relouzat; Coralie Bloch-Queyrat; Nathalie Lambert; Alain Fischer; Geneviève de Saint-Basile; Sylvain Latour
Journal:  J Exp Med       Date:  2005-02-28       Impact factor: 14.307

10.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

Authors:  Shawn D Blackburn; Haina Shin; W Nicholas Haining; Tao Zou; Creg J Workman; Antonio Polley; Michael R Betts; Gordon J Freeman; Dario A A Vignali; E John Wherry
Journal:  Nat Immunol       Date:  2008-11-30       Impact factor: 25.606

View more
  2 in total

1.  Chemical Structure and Immune Activation of a Glucan From Rhizoma Acori Tatarinowii.

Authors:  Wuxia Zhang; Jiaqi He; Yihua Hu; Jingwu Lu; Jinzhong Zhao; Peng Li
Journal:  Front Nutr       Date:  2022-06-29

2.  Trans- and cis-acting effects of Firre on epigenetic features of the inactive X chromosome.

Authors:  He Fang; Giancarlo Bonora; Jordan P Lewandowski; Jitendra Thakur; Galina N Filippova; Steven Henikoff; Jay Shendure; Zhijun Duan; John L Rinn; Xinxian Deng; William S Noble; Christine M Disteche
Journal:  Nat Commun       Date:  2020-11-27       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.